Concepedia

D. Brisgand

DB

Statistics

Publications

5

Citations

1K

H-Index

5

Active since

1994

Affiliations

Institut Gustave Roussy(Current)

D. Brisgand is an author at Institut Gustave Roussy specializing in oncology, medicine, and oncology pharmacotherapy.

Publications per year

1994–2001

5

Publications

5

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

Thierry Le Chevalier, D. Brisgand, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1994 · 824 citations

, , +12

Results of a european randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

François Eschwège, H Sancho-Garnier, D. Chassagne et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 80 citations

, , +7

Long Term Analysis of Survival in the European Randomized Trial Comparing Vinorelbine/Cisplatin to Vindesine/Cisplatin and Vinorelbine Alone in Advanced Non-Small Cell Lung Cancer

Thierry Le Chevalier, D. Brisgand, Jean‐Charles Soria et al. · The Oncologist · 2001 · 68 citations

, , +11

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

Jean‐Charles Soria, D. Brisgand, Thierry Le Chevalier · Annals of Oncology · 2001 · 65 citations

, , +13

[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].

Thierry Le Chevalier, D. Brisgand, Jean Louis Pujol et al. · PubMed · 1996 · 11 citations

, , +7

1–5 of 5